UK markets close in 7 hours 6 minutes

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.090.00 (0.00%)
At close: 03:06PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
11,346
5,479
244
0
Cost of revenue
6,845
3,762
-
-
Gross profit
4,501
1,717
-
-
Operating expenses
Research development
30,103
20,209
13,336
9,743
Selling general and administrative
20,754
13,983
9,642
10,828
Total operating expenses
47,766
34,192
22,978
20,571
Operating income or loss
-43,265
-32,475
-22,734
-20,571
Interest expense
-17
16
33
-
Income before tax
-47,801
-36,041
-22,870
-20,526
Income tax expense
-5,385
-3,494
-3,288
-2,115
Income from continuing operations
-42,416
-32,547
-19,582
-18,411
Net income
-42,416
-32,547
-19,582
-18,411
Net income available to common shareholders
-42,416
-32,547
-19,582
-18,411
Basic EPS
-
-0.40
-0.26
-0.26
Diluted EPS
-
-0.40
-0.26
-0.26
Basic average shares
-
81,776
75,127
70,313
Diluted average shares
-
81,776
75,127
70,313
EBITDA
-
-35,529
-22,355
-20,172